{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:26:16Z","timestamp":1791509176409,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jdermsci.2013.04.032","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T13:05:50Z","timestamp":1372338350000},"page":"212-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Elevated circulating soluble interleukin-2 receptor in patients with non-segmental vitiligo in North American"],"prefix":"10.1016","volume":"71","author":[{"given":"Yu-Ling","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Sheng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2013.04.032_bib0005","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.2011.321","article-title":"Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis","volume":"132","author":"Spritz","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","article-title":"Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo","volume":"25","author":"Ben Ahmed","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1755-148X.2012.01019.x","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","article-title":"T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells","volume":"241","author":"Cheng","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000319248","article-title":"Interleukin-2 and the interleukin-2 receptor complex","volume":"59","author":"Gaulton","year":"1994","journal-title":"Chem Immunol"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0035","first-page":"27","article-title":"Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets","volume":"36","author":"Shahabuddin","year":"1991","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0040","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1126\/science.7770771","article-title":"Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta","volume":"268","author":"Suzuki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2340\/0001555576357360","article-title":"Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1","volume":"76","author":"De Rie","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000247419","article-title":"Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis","volume":"185","author":"Kagi","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1346-8138.1997.tb02292.x","article-title":"Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo","volume":"24","author":"Honda","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0923-1811(98)00070-X","article-title":"Serum concentration of the soluble interleukin-2 receptor in vitiligo patients","volume":"19","author":"Yeo","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2013.04.032_bib0070","first-page":"71","article-title":"Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo: relationship with type and extent of the disease","volume":"12","author":"Franczuk","year":"2004","journal-title":"Acta Dermatovenerol Croat"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181113002107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181113002107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T17:40:28Z","timestamp":1688319628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181113002107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0923181113002107"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2013.04.032","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated circulating soluble interleukin-2 receptor in patients with non-segmental vitiligo in North American","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2013.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}